DGAP-News: Apricus Biosciences Granted Regulatory Guidance With FDA for MycoVa(TM) for the Treatment of Onychomycosis
Apricus Biosciences, Inc.
22.05.2012 16:13
—————————————————————————
SAN DIEGO, 2012-05-22 16:13 CEST (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
(http://www.apricusbio.com) announced today that the United States (–U.S.–)
Food and Drug Administration (–FDA–) has granted the Company–s request for Type
C regulatory guidance from the agency for MycoVa(tm), the Company–s t
